Evidence map›Paper›PMID 34930999›Full record

ArticleOncogene2022

Correction to: Adaptor SH3BGRL promotes breast cancer metastasis through PFN1 degradation by translational STUB1 upregulation.

Shaoyang Zhang, Xuemin Guo, Xiufeng Liu, Zhixiong Zhong, Shulan Yang, Haihe Wang

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shaoyang Zhang *Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0002-0888-5240
Xuemin Guo *Center for Health Examination, Meizhou City People's Hospital, Meizhou, Guangdong Province, China.ORCID http://orcid.org/0000-0003-2929-7461
Xiufeng LiuCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0001-5407-3174
Zhixiong ZhongCenter for Health Examination, Meizhou City People's Hospital, Meizhou, Guangdong Province, China.ORCID http://orcid.org/0000-0002-3200-3105
Shulan YangCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. yangshl3@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-6864-2195
Haihe WangDepartment of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China. wanghaih@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-9302-2334
Sun Yat-sen University · CNMeizhou City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34930999
OpenAlexW4200247697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.